Oncolytics Biotech Inc (ONCY)

12:42 PM

Buy Rating for Oncolytics Biotech Driven by Promising Pelareorep Data in Pancreatic and Colorectal Cancers - TipRanks

12:42 PM

05:55 AM

What drives Oncolytics Biotech Inc. stock priceSuperior trading gains - PrintWeekIndia

05:55 AM

03:51 AM

Is Oncolytics Biotech Inc. a good long term investmentRecord-breaking capital gains - PrintWeekIndia

03:51 AM

Jul 24, 2025

Oncolytics Biotech Inc. Stock Analysis and ForecastConsistently high yield - Autocar Professional

Jul 24, 2025

Jul 24, 2025

Oncolytics Biotech Inc - Baystreet.ca

Jul 24, 2025

Jul 24, 2025

Stocks In Play: Oncolytics Biotech Inc - Barchart.com

Jul 24, 2025

Jul 23, 2025

Oncolytics Biotech® Regains Compliance with Nasdaq Trading Rules - Eastern Progress

Jul 23, 2025

Jul 23, 2025

(ONC) Technical Analysis and Trading Signals (ONC:CA) - news.stocktradersdaily.com

Jul 23, 2025

Jul 23, 2025

What analysts say about Oncolytics Biotech Inc. stockFree Stock Market Real-Time Monitoring - jammulinksnews.com

Jul 23, 2025

Jul 23, 2025

High‑Growth Oncology Market Projected For US$900bn in Revenue Despite Policy Headwinds - The Malaysian Reserve

Jul 23, 2025

Jul 23, 2025

Oncolytics Biotech Highlights Pelareorep’s Potential in Pancreatic Cancer at KOL Event - TipRanks

Jul 23, 2025

Jul 23, 2025

Key Opinion Leader Event Highlights Pelareorep's Compelling Pancreatic and Gastrointestinal Data And Future Potential - Your Wyoming Link

Jul 23, 2025

Jul 23, 2025

Cancer Surge Meets Funding Crunch as Breakthrough Biotechs Line Up Milestones in 2025 - Baystreet.ca

Jul 23, 2025

Jul 22, 2025

Pancreas Cancer Becoming Top Focus for Biotech Co.? - streetwisereports.com

Jul 22, 2025

Jul 22, 2025

Oncolytics Biotech Regains Compliance With Nasdaq's Minimum Bid Price Rule - 富途牛牛

Jul 22, 2025

Jul 22, 2025

Oncolytics Biotech Regains Nasdaq Compliance as of July 22, 2025 - TipRanks

Jul 22, 2025

Jul 22, 2025

Oncolytics Biotech regains compliance with Nasdaq listing requirements - Investing.com

Jul 22, 2025

Jul 22, 2025

Oncolytics Biotech regains compliance with Nasdaq listing requirements By Investing.com - Investing.com Nigeria

Jul 22, 2025

Jul 22, 2025

Oncolytics regains Nasdaq compliance - TipRanks

Jul 22, 2025

Jul 21, 2025

How To Trade (ONC) (ONC:CA) - news.stocktradersdaily.com

Jul 21, 2025

Jul 19, 2025

Oncolytics names Jared Kelly as CEO - MSN

Jul 19, 2025

Jul 17, 2025

Oncolytics Biotech (ONCY) up more than 100% since Jun 23 - AInvest

Jul 17, 2025

Jul 16, 2025

What makes Oncolytics Biotech Inc. stock price move sharplyAnalyst Grade Signals - beatles.ru

Jul 16, 2025

Jul 16, 2025

Cancer Pipeline Milestones Coming Fast as Regulators Revisit Research Priorities - Cantech Letter

Jul 16, 2025

Jul 16, 2025

Emerging Oncology Breakthroughs Signal Opportunity Despite Research Funding Crunch - Baystreet.ca

Jul 16, 2025